Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

Parkinson Disease activates KCNG1. 1 / 1

| 1

➶

reach

"To gain insights into the role of Erk signaling in Mek inhibition of ESCs, six samples, WT KH2 ESCs treated with or without PD for 48h (KH2_PD and KH2, respectively), iErk1; Erk KO ESCs cultured with Dox (P0), 48 and 96h after Dox withdrawal (P1 and P2, respectively), and iErk1; Erk KO ESCs cultured without Dox for 96h and treated with PD in the last 48h (P2_PD), are subjected to RNA sequencing (RNA-seq) analysis."

26981366

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...